首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1907968

基因編輯市場按產品、技術、應用、最終用戶和地區分類

Gene Editing Market, By Product, By Technology, By Application, By End User, By Geography

出版日期: 2025年12月22日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

基因編輯市場預計在 2025 年達到 48 億美元，預計到 2032 年將達到 95.1 億美元，2025 年至 2032 年的複合年成長率為 10.2%。

分析範圍		分析詳情
基準年	2024	市場規模（2025 年）	48億美元
效能數據	2020-2024	預測期	2025-2032
預測期（2025-2032 年）複合年成長率	10.20%	預計金額（2032 年）	95.1億美元

基因編輯是一種基因工程技術，它允許對生物體的DNA進行標靶修改。技術進步顯著提高了基因編輯的範圍和效率，為治療性基因修飾和性狀改良提供了經濟高效的選擇。全球基因編輯市場涵蓋了與基因組編輯相關的工具、產品和服務，應用於各種研究、治療和農業領域。過去十年，基因編輯已發展成為最尖端科技，可用於疾病治療和農業。隨著精準性、安全性和遞送方法的不斷改進，基因編輯有望顛覆現有產業，並革新現代生物技術。

市場動態

全球基因編輯市場的發展主要得益於來自公共和私人機構對生物技術研發投入的不斷成長。包括CRISPR-Cas9在內的基因編輯工具的進步，正在拓展其潛在的治療應用，並推動市場成長。定序和合成成本的降低也促進了基因編輯技術的普及。然而，基因編輯作物和治療產品的商業化仍面臨監管方面的挑戰，這在一定程度上限制市場成長。此外，缺乏成熟的遞送方法和脫靶編輯問題仍然是主要挑戰。體內遞送系統的開發為拓展至新的疾病治療領域提供了機會。農業領域的成功商業性應用也預示著基因編輯技術具有良好的長期前景。

本報告的主要特點

本報告對全球基因編輯市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
全球基因編輯市場的主要企業將根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使負責人和公司經營團隊能夠就未來的產品發布、產品更新、市場擴張和行銷策略做出明智的決策。
《全球基因編輯市場》報告面向該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過各種用於分析全球基因編輯市場的策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

CRISPR Therapeutics
Editas Medicine
Intellia Therapeutics
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Horizon Discovery
Sangamo Therapeutics
Cellectis
Genomatix
Integrated DNA Technologies
New England Biolabs
Takara Bio
Bio-Rad Laboratories
Ginkgo Bioworks

第10章分析師建議

機會
分析師觀點
Coherent Opportunity Map (COM)

第11章參考文獻與分析方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI7741

Gene Editing Market is estimated to be valued at USD 4.80 Bn in 2025 and is expected to reach USD 9.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 4.80 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.20%	2032 Value Projection:	USD 9.51 Bn

Gene editing is a type of genetic engineering which allows targeted changes to be made to an organism's DNA. Technologies, have greatly expanded the scope and efficiency of gene editing by providing cost-effective options for therapeutic modifications and trait improvements. The global gene editing market encompasses tools, products, and services related to gene editing of genomes in various research, therapeutic, and agricultural applications. Over the past decade, gene editing has become a frontier technology with significant potential for disease treatment and agriculture. With continued improvements in precision, safety, and delivery methods, is anticipated to disrupt established industries and transform modern biotechnology.

Market Dynamics

The global gene editing market is driven by growing investments in biotechnology research and development from both private and public sources. Advancements in CRISPR-Cas9 and other gene editing tools have expanded the potential for therapeutic applications, boosting market growth. Reduced costs of sequencing and synthesis are also improving access to gene editing technologies. However, regulatory concerns around the commercialization of gene edited crops and therapeutic products continue to restrain market growth. Additionally, lack of established delivery methods and off-target editing remain major challenges. The development of in vivo delivery systems presents an opportunity for expansion into new disease treatment areas. Successful commercial applications in agriculture also present a promising prospect over the long term.

Key Features of the Study

This report provides in-depth analysis of the global gene editing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gene editing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Horizon Discovery, Sangamo Therapeutics, Cellectis, Genomatix, Integrated DNA Technologies, New England Biolabs, Takara Bio, Bio-Rad Laboratories, and Ginkgo Bioworks
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global gene editing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene editing market

Market Segmentation

Product Insights (Revenue, USD Bn, 2025 - 2032)
- Kits
- Reagents
- Software
Technology Insights (Revenue, USD Bn, 2025 - 2032)
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Transcription Activator-Like Effector Nuclease (TALEN)
- ZFN (Zinc Finger Nucleases)
- Meganucleases
- Prime Editing
- Others (PiggyBac, etc.)
Application Insights (Revenue, USD Bn, 2025 - 2032)
- Cell Line Engineering
- Genetic Engineering
- Drug Discovery
- Clinical Diagnostics
- Xenotransplantation
- Agriculture
End User Insights (Revenue, USD Bn, 2025 - 2032)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Diagnostic Companies
- Others
Regional Insights (Revenue, USD Bn, 2025 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Horizon Discovery
- Sangamo Therapeutics
- Cellectis
- Genomatix
- Integrated DNA Technologies
- New England Biolabs
- Takara Bio
- Bio-Rad Laboratories
- Ginkgo Bioworks

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Gene Editing Market, By Product
- Global Gene Editing Market, By Technology
- Global Gene Editing Market, By Application
- Global Gene Editing Market, By End User
- Global Gene Editing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends

4. Global Gene Editing Market, By Product, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Gene Editing Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transcription Activator-Like Effector Nuclease (TALEN)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
ZFN (Zinc Finger Nucleases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Meganucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Prime Editing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (PiggyBac, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gene Editing Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cell Line Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Agriculture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gene Editing Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gene Editing Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

CRISPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Editas Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Intellia Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Horizon Discovery
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sangamo Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genomatix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Integrated DNA Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ginkgo Bioworks
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies